FNCH insider filings
Finch Therapeutics Group, Inc. — 42 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-10. Screen FNCH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for FNCH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Finch Therapeutics Group, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-10 | 4 | SMISEK JEFFERY A — Director | Gift (G): 384 @ $0 · Gift (G): 383 @ $0 | EDGAR |
| 2024-05-24 | 4 | SMISEK JEFFERY A — Director | Gift (G): 3,750 @ $0 | EDGAR |
| 2024-03-29 | 4 | SMISEK JEFFERY A — Director | Sale (S): 6,642 @ $2.57 · Sale (S): 1,600 @ $2.61 | EDGAR |
| 2023-11-27 | 4 | SMISEK JEFFERY A — Director | Sale (S): 1,470 @ $3.64 | EDGAR |
| 2023-06-23 | 4/A | Blischak Matthew P. — Chief Executive Officer | Grant/award (A): 962,899 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Blischak Matthew P. — Chief Executive Officer | Grant/award (A): 962,899 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Lange Christian H. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Haft Nicholas — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Graf Susan E — Director | Purchase (P): 5,010 @ $0.27 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Shumway Chris — Director, 10% owner | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | FERRANTE DOMENIC J — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | SMISEK JEFFERY A — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Blaustein Marc — Chief Operating Officer | Sale (S): 4,619 @ $0.38 | EDGAR |
| 2022-10-25 | 4 | Blaustein Marc — Chief Operating Officer | Sale (S): 3,636 @ $1.39 | EDGAR |
| 2022-10-25 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Sale (S): 3,636 @ $1.39 | EDGAR |
| 2022-06-15 | 4 | Lange Christian H. — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Blaustein Marc — Chief Operating Officer | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2022-06-15 | 4 | Viney Joanne L. — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Haft Nicholas — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Hamood Samuel A — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Graf Susan E — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2022-06-15 | 4 | Shumway Chris — Director, 10% owner | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | FERRANTE DOMENIC J — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-06-15 | 4 | SMISEK JEFFERY A — Director | Grant/award (A): 44,843 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Blaustein Marc — Chief Operating Officer | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | PERRY GREGORY D — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Haft Nicholas — Director | Purchase (P): 63,850 @ $10.18 | EDGAR |
| 2021-12-21 | 4 | Vittiglio Joseph — Chief Business & Legal Officer | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2021-10-05 | 4 | Hamood Samuel A — Director | Grant/award (A): 25,543 (derivative) @ $0 | EDGAR |
| 2021-09-10 | 4 | Blaustein Marc — Chief Operating Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-05-14 | 4 | Viney Joanne L. — Director | Grant/award (A): 23,419 (derivative) @ $0 | EDGAR |
| 2021-04-27 | 4 | Graf Susan E — Director | Grant/award (A): 23,419 (derivative) @ $0 | EDGAR |
| 2021-03-25 | 4 | Haft Nicholas — Director | Conversion (C): 172,942 · Conversion (C): 143,831 · Conversion (C): 1,064,466 · Conversion (C): 366,093 · Conversion (C): 212,893 · Conversion (C): 1,150,481 · +7 more | EDGAR |
| 2021-03-25 | 4 | Crestovo Investor LLC — Director, 10% owner Shumway Chris — Director, 10% owner | Conversion (C): 11,906,147 · Purchase (P): 735,294 @ $17 · Conversion (C): 8,672,117 (derivative) · Conversion (C): 1,064,466 (derivative) · Conversion (C): 1,172,480 (derivative) · Conversion (C): 997,084 (derivative) | EDGAR |
| 2021-03-25 | 4 | FERRANTE DOMENIC J — Director | Conversion (C): 141,928 · Conversion (C): 300,948 · Conversion (C): 90,378 · Purchase (P): 102,941 @ $17 · Conversion (C): 141,928 (derivative) @ $0 · Conversion (C): 300,948 (derivative) @ $0 · +1 more | EDGAR |
| 2021-03-25 | 4 | SMISEK JEFFERY A — Director | Conversion (C): 894,955 · Conversion (C): 141,928 · Conversion (C): 297,178 · Conversion (C): 272,245 · Purchase (P): 88,235 @ $17 · Conversion (C): 894,955 (derivative) @ $0 · +3 more | EDGAR |
| 2021-03-18 | 4 | Smith Mark Burnham — Chief Executive Officer, Director | Grant/award (A): 595,402 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | Kassam Zain — Chief Medical Officer | Grant/award (A): 69,232 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | Vittiglio Joseph — General Counsel and Secretary | Grant/award (A): 34,616 (derivative) @ $0 · Grant/award (A): 60,578 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | PERRY GREGORY D — Chief Financial Officer | Grant/award (A): 55,386 (derivative) @ $0 | EDGAR |
Recent 8-K events — Finch Therapeutics Group, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-10-21 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-05-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-05-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-04-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-02-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2023-11-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-07-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2023-06-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-06-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FNCH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs